A detailed history of Sittner & Nelson, LLC transactions in Novartis Ag stock. As of the latest transaction made, Sittner & Nelson, LLC holds 8,769 shares of NVS stock, worth $969,500. This represents 0.47% of its overall portfolio holdings.

Number of Shares
8,769
Previous 9,045 3.05%
Holding current value
$969,500
Previous $874,000 6.75%
% of portfolio
0.47%
Previous 0.45%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $25,549 - $29,634
-276 Reduced 3.05%
8,769 $933,000
Q1 2024

May 10, 2024

BUY
$95.27 - $108.47 $4,096 - $4,664
43 Added 0.48%
9,045 $874,000
Q4 2023

Feb 12, 2024

SELL
$92.27 - $101.54 $47,334 - $52,090
-513 Reduced 5.39%
9,002 $908,000
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $18,946 - $21,026
-200 Reduced 2.06%
9,515 $969,000
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $362,955 - $411,561
-3,923 Reduced 28.77%
9,715 $980,000
Q1 2023

May 09, 2023

BUY
$80.03 - $92.81 $4,481 - $5,197
56 Added 0.41%
13,638 $1.25 Million
Q4 2022

Feb 01, 2023

BUY
$75.55 - $92.52 $41,174 - $50,423
545 Added 4.18%
13,582 $1.23 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $123,106 - $143,979
1,650 Added 14.49%
13,037 $991,000
Q2 2022

Aug 12, 2022

BUY
$80.52 - $93.75 $100,650 - $117,187
1,250 Added 12.33%
11,387 $963,000
Q1 2022

May 10, 2022

BUY
$80.11 - $90.62 $11,135 - $12,596
139 Added 1.39%
10,137 $890,000
Q4 2021

Feb 09, 2022

BUY
$79.7 - $88.13 $23,910 - $26,439
300 Added 3.09%
9,998 $875,000
Q3 2021

Nov 12, 2021

BUY
$81.78 - $95.14 $39,499 - $45,952
483 Added 5.24%
9,698 $793,000
Q2 2021

Aug 12, 2021

BUY
$85.24 - $94.15 $21,310 - $23,537
250 Added 2.79%
9,215 $841,000
Q1 2021

May 06, 2021

BUY
$83.5 - $98.47 $1,670 - $1,969
20 Added 0.22%
8,965 $766,000
Q4 2020

Feb 16, 2021

BUY
$78.07 - $94.43 $698,336 - $844,676
8,945 New
8,945 $845,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Sittner & Nelson, LLC Portfolio

Follow Sittner & Nelson, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sittner & Nelson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sittner & Nelson, LLC with notifications on news.